Click for Cover Page
Cover NEWS Support Groups Advocacy Search
Upfront MedBriefs EatingWell Voices Grassroots PCaLinks

ARCHIVE
RIBBONS
STAMPS
POSTERS
TIMELINE


Grassroots

Patient Advocates Help UCSF Win Multi Million NCI SPORE Grant
by
Howard Waage


Up and running

California Prostate Cancer Coalition (CPCC)
now online.


New York Prostate Cancer Coalition is on the move too. Contact Dennis O'Hara, Man to Man organizer in Poughkeepsie, NY, co-author of "Support Group." E-mail Dennis at i[email protected]
 

 

October 2, 2000 /PSA Rising/. University of California San Francisco has won a muliti-million dollar grant for prostate cancer research. The money will come from the National Cancer Institute (NCI) in the form of a SPORE (Specialized Program of Research Excellence) grant.

"It is now official," Art Kern, a spokesperson for the Bay Area Prostate Cancer Advocacy Core Group, said yesterday. "UCSF has become the fourth prostate cancer SPORE in the country." Others are at Baylor, Johns Hopkins and University of Michigan.

The research money will be given at the rate of about one and a half million dollars a year for five years. It can be renewed at the next cycle. There is money for infrastructure on top of the $1.5 million.

The UCSF Prostate Cancer Advocacy Core Group submitted a bid for this grant to the National Cancer Insititute (NCI) earlier this year. NCI already dedicates SPORE grants for several specific cancers, Kern says. Breast cancer has SPORE status at UCSF and at five other US centers. Prostate cancer, until now, had only three other SPORE grant sites.

SPORE money is aimed at promoting interdisciplinary research that will spark advances in prevention, diagnosis and treatment of cancer. Unlike traditional National Institutes of Health (NIH) grants, a SPORE grant provides funding for scientists and clinical investigators to work together to bring research advances to patients.

To win a SPORE, an institution must demonstrate a high degree of collaboration between first-rate scientists and first-rate clinicians, along with a queue of promising, first-rate translational research projects.

"UCSF is long and strong on all of this," Kern said. And, he says, "the presence of an active patient advocates group working with the university is viewed as a plus by the NCI in considering SPORE applications."

Marc Shuman led the team that won the SPORE, and Peter R. Carroll M.D., Eric Small M.D., Mack Roach III M.D., and Frank McCormick Ph.D. helped bring it about. The funding begins immediately (as of September 25).


E-mail [email protected]

Top
PSA Rising
prostate cancer activist news
http://www.psa-rising.com
© 1997-2000